AMZN
Amazon.com, Inc.
AMZN has the edge over ULTA overall, supported by stronger valuation and stronger modeled upside.
ULTA
Ulta Beauty, Inc.
ULTA's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
ULTA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
ULTA's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over ULTA in the historical PE scenario, which offers more potential upside but is not a forecast.
ULTA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $448 | -31% |
| Fair | 20x | $561 | -14% |
| Forward | 21x | $651 | — |
| Current | 24x | $651 | — |
| Expensive | 29x | $809 | +24% |
Historical ranges are pointers, not guarantees.
ULTA's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 21x next year's earnings, in its fair range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
ULTA Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Moderate | |
| High |
ULTA has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over ULTA on earnings, with more consistent year-over-year improvement.
ULTA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $31.27 | +14% |
| Q3 2026 | $27.45 | +5.4% |
| Q2 2026 | $26.68 | +4.3% |
| Q1 2026 | $25.64 | +1.2% |
| Q4 2025 | $26.05 | +4.3% |
| Q3 2025 | $26.05 | +4.6% |
| Q2 2025 | $25.57 | -0.2% |
| Q1 2025 | $25.34 | -2.7% |
| Q4 2024 | $24.97 | +1.3% |
ULTA earned $27.45 per share over the past year, up 5.4% from the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over ULTA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over ULTA on profitability, with a higher operating margin.
ULTA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3B | +8.9% |
| Q2 2026 | $3.2B | +11% |
| Q1 2026 | $3.9B | +12% |
| Q4 2025 | $2.9B | +13% |
| Q3 2025 | $2.8B | +9.3% |
| Q2 2025 | $2.8B | +4.5% |
| Q1 2025 | $3.5B | -1.9% |
| Q4 2024 | $2.5B | +1.7% |
ULTA's revenue has grown year over year for six quarters in a row: $3B last quarter, up 8.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | +0.1 points |
| Q2 2026 | 14% | +0.1 points |
| Q1 2026 | 12% | -2.6 points |
| Q4 2025 | 11% | -1.8 points |
| Q3 2025 | 12% | -0.5 points |
| Q2 2025 | 14% | -0.6 points |
| Q1 2025 | 15% | +0.3 points |
| Q4 2024 | 13% | -0.6 points |
ULTA's operating margin was 13% last quarter, about level with the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
ULTA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $38.4M | +96% |
| Q2 2026 | $203.6M | +44% |
| Q1 2026 | $989M | +2.7% |
| Q4 2025 | -$81.6M | +$89.4M |
| Q3 2025 | $19.6M | -81% |
| Q2 2025 | $141M | +106% |
| Q1 2025 | $962.6M | -3.2% |
| Q4 2024 | -$171.1M | +$6M |
ULTA has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
ULTA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.1% | -902K shares |
| 1 year | -4.5% | -2M shares |
| 3 years | -14% | -6.8M shares |
| 5 years | -22% | -12M shares |
| Available history | -25% | -14.7M shares |
ULTA has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $247.9M |
| Q2 2026 | $545.3M |
| Q1 2026 | $197.4M |
| Q4 2025 | $224.7M |
| Q3 2025 | $109.5M |
| Q2 2025 | $369.8M |
| Q1 2025 | $237.9M |
| Q4 2024 | $263.6M |
ULTA spent $1.2B buying back its own shares over the past year, up 24% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
ULTA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.0x | Very low |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.4x | Net Cash |
| Q4 2024 | 0.0x | Very low |
ULTA has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
ULTA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 86.9 | Overbought |
ULTA's weekly RSI is 68 (neutral) and its Stochastic is 87 (overbought).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over ULTA on valuation relative to its sector.
ULTA PE vs Consumer Cyclical Sector
| Metric | ULTA | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 18x | 32% above |
| PE % | 72 | 47 | 25 pts above |
ULTA is trading at 24x earnings, a 32% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
ULTA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $601.6 | 8.2% above |
| 20 week MA | $548.9 | 19% above |
| 50 week MA | $565.1 | 15% above |
| 100 week MA | $508.9 | 28% above |
| 200 week MA | $475.4 | 37% above |
ULTA is in an uptrend: it's above all five of its weekly moving averages, and 37% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over ULTA on returns for 2026, with the stronger performance.
ULTA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $253.2 | $264.6 | +4.5% |
| 2021 | $264.6 | $392.4 | +48% |
| 2022 | $392.4 | $456.4 | +16% |
| 2023 | $456.4 | $490.0 | +7.4% |
| 2024 | $490.0 | $442.2 | -9.8% |
| 2025 | $442.2 | $607.5 | +37% |
| 2026 YTD | $607.5 | $651.0 | +7.2% |
ULTA has finished higher in five of the last six years. It's up 7.2% so far in 2026.